To what extent is the role of (MDGs) and now the
(SDGs) in improving Indonesia’s tuberculosis
program and situations?
DINDA SINTA RAHAYU
Z5446687
How Big Tuberculosis Problems in Indonesia?
• Among 30 countries with the highest burden of Tuberculosis
• High rate of community transmission, due to high
population density
MDGS and SDGs have targets for tuberculosis problems in many countries, including Indonesia. With these targets, the Indonesian government is motivated to develop and innovate the newest strategy to eliminate tuberculosis in 2030 and eradicate tuberculosis in 2050.
THESIS STATEMENT
MDGs in Influences of TB Management Effort in Indonesia (2000-2015)
MDGs Target
(reduce the number of new TB cases by
2015)
WHO (STOP TB Strategy and DOTS)
Regulation of the Minister of Health
Number 565 concerning the
National Strategy for
Tuberculosis Control
What we Achieved during this time period of MDGs?
Source: Ministry of Health, Tuberculosis
Data in 2009
SDGs in Influences of TB Management Effort in Indonesia
SDGs Target
(End the tuberculosis epidemic (2030))
WHO (END-TB strategy) - 90% reduction in TB
deaths by 2030
-80% reduction in TB incidence
--National strategy for TB prevention and Control
until 2024
-Protocol for Tuberculosis Care During Covid-19
Pandemic
Tuberculosis situations after 2015?
Before Covid-19 Pandemic
TB cases was still high due to growing population, HOWEVER case notification rate was still good
treatment success rates improved and even surpassed the global trend
During Covid-19 Pandemic
In the first half of 2020, 25– 30%
reduction in TB notifications
“Iceberg Phenomenon” of TB
Cases
MDGs and SDGs do not always produce effective results in tb situations in Indonesia. However, with the targets set by the MDGs and SDGS, the Government of Indonesia continues to innovate to develop strategies and collaborate with other organizations and other countries to achieve the target
of ending the TB epidemic in 2030.
Conclusion
REFERENCES
Chan, G., Triasih, R., Nababan, B., du Cros, P., Wilks, N., Main, S., Huang, G. K. L., Lin, D., Graham, S. M., Majumdar, S. S., Bakker, M., Khan, A., Khan, F. A., & Dwihardiani, B.
(2021). Adapting active case-finding for TB during the COVID-19 pandemic in Yogyakarta, Indonesia. Public Health Action, 11(2), 41–49. https://doi.org/10.5588/pha.20.0071 Iskandar, D., Suwantika, A. A., Pradipta, I. S., Postma, M. J., & van Boven, J. F. M. (2023).
Clinical and economic burden of drug-susceptible tuberculosis in Indonesia: national trends 2017–19. The Lancet Global Health, 11(1), e117–e125.
https://doi.org/10.1016/S2214-109X(22)00455-7
Kementrian Kesehatan Republik Indonesia. (2011). Strategi nasional pengendalian TB di Indonesia 2010-2014.
Lestari, T., Fuady, A., Yani, F. F., Putra, I. W. G. A. E., Pradipta, I. S., Chaidir, L., Handayani, D., Fitriangga, A., Loprang, M. R., Pambudi, I., Ruslami, R., & Probandari, A. (2023). The development of the national tuberculosis research priority in Indonesia: A comprehensive mixed-method approach. PLoS ONE, 18(2 February).
https://doi.org/10.1371/journal.pone.0281591
Sejati, A., & Sofiana, L. (2015). Faktor-faktor terjadinya tuberkulosis. Jurnal Kesehatan Masyarakat, 10(2), 122–128. http://journal.unnes.ac.id/nju/index.php/kemas
United States Agency International Development. (2021). Indonesia TB recovery plan to mitigate the impact of Covid-19. USAID. https://www.usaid.gov/sites/default/files/2022- 05/Recovery_Plan_Indonesia_FINAL-remediated.pdf